Rozalina Mccoy is an Endocrinologist in Baltimore, Maryland. Dr. Mccoy has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Pancreaticoduodenectomy.

Dr. Sudipa Sarkar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include endocrinology. She received her M.D. from Yale School of Medicine. She completed her residency in internal medicine at Yale-New Haven Hospital and performed a fellowship in endocrinology, diabetes and metabolism at Vanderbilt University Medical Center. Dr. Sarkar joined the Johns Hopkins faculty in 2017. Dr. Sarkar is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Diabetic Neuropathy, and Sleeve Gastrectomy.

Sherita Golden is an Endocrinologist in Baltimore, Maryland. Dr. Golden is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Obesity, and Hormone Replacement Therapy (HRT).

Justin Tcheugui is an Endocrinologist in Baltimore, Maryland. Dr. Tcheugui is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Gestational Diabetes.

Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Sheela N. Magge, M.D., M.S.C.E., is a pediatric endocrinologist and the director of the Division of Pediatric Endocrinology, as well as the Lawson Wilkins Endowed Chair of Pediatric Endocrinology at Johns Hopkins Children’s Center. Dr. Magge’s expertise includes the diagnosis and treatment of endocrine disorders in children and adolescents. Primary related conditions that she treats include type 2 diabetes mellitus, pre-diabetes, obesity, congenital insulin resistance syndromes, congenital lipodystrophy and polycystic ovary syndrome. Dr. Magge is an active member of the National Pediatric Endocrine Society. She is also a standing member of the National Institutes of Health (NIH) Human Studies of Diabetes and Obesity Study Section. A professor of pediatrics, Dr. Magge obtained a master’s degree in clinical epidemiology from the University of Pennsylvania. Dr. Magge is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Obesity, Type 2 Diabetes (T2D), Congenital Hyperinsulinism, and Maturity Onset Diabetes of the Young.

Dr. Jodi Segal is a professor of medicine at the Johns Hopkins University School of Medicine. She has joint appointments in health policy and management, and epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Segal is internationally recognized as a clinician-investigator in comparative effectiveness research and pharmacoepidemiology. She trains investigators to conduct research to advance Johns Hopkins Medicine as a learning health system. She serves as the associate director of the Center for Health Services and Outcomes Research (CHSOR) and the co-director of the Center for Drug Safety and Effectiveness (CDSE), both in the School of Public Health. Dr. Segal received a B.S. from The Pennsylvania State University. She earned her M.D. from the University of Pittsburgh School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her residency at the University of Chicago and a fellowship in general nternal medicine at Johns Hopkins. She is a member of Phi Beta Kappa and Alpha Omega Alpha. Dr. Segal is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Giant Papillary Conjunctivitis, Type 2 Diabetes (T2D), Vernal Keratoconjunctivitis, and Allergic Conjunctivitis.

Todd T. Brown, MD, PhD is a clinical investigator who focuses on body composition, metabolic, and skeletal abnormalities observed in people with HIV, particularly as related to aging. Through translational investigation, epidemiologic studies, and clinical trials, he has been interested in understanding the pathogenesis of glucose disorders, fat changes, hormonal dysregulation, and osteoporosis in people with HIV, the consequences of these conditions (eg cardiovascular disease, frailty), and their optimal evaluation and management. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Low Blood Sugar, Osteoporosis, Malnutrition, Gastric Bypass, and Gastrostomy.

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Amal Hassan Ahmed Awadalla, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Faculty of Medicine University of Khartoum, and completed her residency at Queens Hospital Center. Dr. Awadalla is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Neurosarcoidosis, and Sarcoidosis.

Tara Hebert, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Johns Hopkins University School of Medicine, and also completed her residency in internal medicine at Johns Hopkins Medicine School of Medicine. Dr. Hebert is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Maturity Onset Diabetes of the Young, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Jonathan Rich is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Rich is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Heart Failure, Hypertension, Type 2 Diabetes (T2D), Heart Transplant, and Lung Transplant.

Colleen Leavitt, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians. She received her medical degree and completed her residency in medicine & pediatrics at Loyola University School of Medicine. Dr. Leavitt is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Dr. Sujay Pathak holds dual roles with Johns Hopkins Community Physicians as a primary care provider, and with the Johns Hopkins University School of Medicine, as director of the Advanced Ambulatory Clerkship. This position places him squarely at the intersection of primary care theory and practice. He brings both the theoretical expertise and the immense clinical resources of Johns Hopkins Medicine to the clinical care of individuals from all walks of life. As such, he holds himself to the standard of our great primary care leaders in the division of General Internal Medicine, and exemplifies for learners and patients the sort of personalized, expert, compassionate, and high-value care that you'd expect for yourself or your family. As the Physician Quality Champion for both the JHCP Remington Site, as well as for Johns Hopkins Community Physicians more broadly, Dr. Pathak helps JHCP providers embrace the future of healthcare and adapt their practice style to more effectively manage their patient panels. As such, he works to transform healthcare to meet the complex needs of our Johns Hopkins entire patient population, keeping their conditions well-managed, their preventive care needs met, and ultimately, ensuring the best possible outcome for each one. Videos The Hospital Elective: How a personal experience led one provider to create a chance for med students to 'walk in the shoes' of non physicians. Dr. Pathak is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Familial Hypertension, and Hypertension.

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy.

Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Dr. Bennett practices all aspects of primary care medicine, including preventive care and coordiantion of care with other specialists. She has particular interests in weight management and women's health care. She sees patients at Johns Hopkins Bayview Medical Center. Dr. Bennett is an Assistant Professor in the Division of General Internal Medicine, with joint appointments at The Johns Hopkins University Bloomberg School of Public Health. Dr. Bennett is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Obesity, Gestational Diabetes, Peripheral Artery Disease, and Type 2 Diabetes (T2D).

Anthony J. Harrell, M.D., practices internal medicine at Johns Hopkins Community Physicians Greater Dundalk. He received his medical degree from Meharry Medical College in Nashville, and completed his residency at Baptist Hospital in Tennessee. Dr. Harrell is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol.